CytoMed Therapeutics Files 6-K for Annual Shareholder Meeting
Ticker: GDTC · Form: 6-K · Filed: May 16, 2025 · CIK: 1873093
| Field | Detail |
|---|---|
| Company | Cytomed Therapeutics LTD (GDTC) |
| Form Type | 6-K |
| Filed Date | May 16, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: shareholder-meeting, proxy-statement, administrative
TL;DR
CytoMed Therapeutics filed a 6-K for its upcoming shareholder meeting, including proxy materials.
AI Summary
CytoMed Therapeutics Limited filed a Form 6-K on May 16, 2025, to report information related to its upcoming annual general meeting of shareholders. The filing includes the Notice of Annual General Meeting and Proxy Statement, along with a Form of Proxy Card.
Why It Matters
This filing provides shareholders with essential information and materials needed to participate in the company's annual general meeting, including voting procedures.
Risk Assessment
Risk Level: low — The filing is routine administrative information for an upcoming shareholder meeting and does not contain new financial or operational risks.
Key Players & Entities
- CytoMed Therapeutics Limited (company) — Registrant
- 001-41677 (company) — Commission File Number
- May 16, 2025 (date) — Filing Date
FAQ
What is the purpose of this Form 6-K filing?
The Form 6-K is filed in connection with the annual general meeting of shareholders of CytoMed Therapeutics Limited and includes the Notice of Annual General Meeting and Proxy Statement and Form of Proxy Card.
When was this Form 6-K filed?
This Form 6-K was filed on May 16, 2025.
What are the key documents included in this filing?
The key documents included are the Notice of Annual Shareholder Meeting and Proxy Statement (Exhibit 99.1) and the Form of Proxy Card (Exhibit 99.2).
What is the company's principal executive office address?
The company's principal executive office is located at 1 Commonwealth Lane #08-22, Singapore 149544.
Does CytoMed Therapeutics file annual reports under Form 20-F or 40-F?
CytoMed Therapeutics indicates it files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 16, 2025 regarding CytoMed Therapeutics Ltd (GDTC).